Trump's Drug Pricing Deal Sparks Mixed Reactions in Pharma
TL;DR Summary
President Trump claimed a victory in reducing U.S. drug prices by pressuring Pfizer to lower costs, but the deal also benefited Pfizer by allowing it to sell some drugs at lower prices in the U.S. similar to other countries.
- Trump claimed a win on drug prices, but Big Pharma also scored The Washington Post
- Why Pfizer’s Trump Deal Is Good News for All of Big Pharma The Wall Street Journal
- Inside TrumpRx and its unusual launch Axios
- President announces TrumpRx website for drugs, and pricing deal with Pfizer NPR
- Local pharmacists react to 'TrumpRx' 10tv.com
Reading Insights
Total Reads
0
Unique Readers
17
Time Saved
0 min
vs 1 min read
Condensed
30%
56 → 39 words
Want the full story? Read the original article
Read on The Washington Post